M&A Deal Summary |
|
|---|---|
| Date | 2013-03-15 |
| Target | CoreLab Partners |
| Sector | Life Science |
| Buyer(s) | BioClinica |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Merger |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Life Science |
| Revenue | 84M USD (2013) |
Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market, for people around the world. Through deep medical, scientific, and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serves more than 500 pharmaceutical, biotechnology, and device organizations including the top 20 biopharmaceutical companies and leading CROs through offices in North America, Europe, and Asia. Bioclinica was formed in 1990 and is based in Princeton, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 13 |
| Sector (Life Science) | 1 of 3 |
| Type (Merger) | 1 of 1 |
| State (New Jersey) | 1 of 1 |
| Country (United States) | 4 of 12 |
| Year (2013) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-03-26 |
TranSenda International
Bellevue, Washington, United States TranSenda International LLC is a provider of clinical trial management software (CTMS) solutions. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-03-12 |
CCBR-SYNARC
Newark, California, United States CCBR-SYNARC, Inc. is a medical image-analysis, subject-recruitment, and biochemical marker services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 19 of 55 |
| Sector (Life Science) | 7 of 25 |
| Type (Merger) | 1 of 4 |
| State (New Jersey) | 2 of 5 |
| Country (United States) | 19 of 51 |
| Year (2013) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-03-13 |
BioClinica
Princeton, New Jersey, United States Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market, for people around the world. Through deep medical, scientific, and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serves more than 500 pharmaceutical, biotechnology, and device organizations including the top 20 biopharmaceutical companies and leading CROs through offices in North America, Europe, and Asia. Bioclinica was formed in 1990 and is based in Princeton, New Jersey. |
Buy | $123M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-11-13 |
CRI Lifetree
Mount Laurel, New Jersey, United States CRI Lifetree has grown to include several clinical research facilities in Southeastern Pennsylvania and Southern New Jersey, including venues for both inpatient and outpatient studies. The company has extensive experience in conducting clinical trials related to central nervous system (CNS) disorders – one of the most rapidly growing segments of pharmaceutical research. |
Sell | - |
